Related Experiment Video
Updated: Aug 24, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
A serum amyloid A and LDL complex as a new prognostic marker in stable coronary artery disease
Ken Ogasawara1, Shinichi Mashiba, Youichiro Wada
1The Cardiovascular Institute, Roppongi 7-3-10 Minato-ku, Tokyo 106-0032, Japan. ij3k-ogsw@asahi-net.or.jp
Insights
The SAA/LDL complex, a novel inflammatory marker, shows greater sensitivity than CRP or SAA in predicting prognosis for patients with stable coronary artery disease (CAD). This finding offers a new tool for risk stratification in cardiovascular disease management.
Area of Science:
- Cardiovascular Medicine
- Biomarkers
- Inflammation Research
Background:
- Prognostic value of acute phase proteins like CRP and SAA in acute coronary syndrome is known.
- The predictive capability of these inflammatory markers in stable coronary artery disease (CAD) remains unclear.
- This study aimed to clarify the prognostic significance of inflammatory markers in stable CAD patients.
Purpose of the Study:
- To evaluate the prognostic value of serum amyloid A/low-density lipoprotein (SAA/LDL) complex in patients with stable coronary artery disease (CAD).
- To compare the predictive power of SAA/LDL complex against established markers like C-reactive protein (CRP) and serum amyloid A (SAA).
Main Methods:
- Prospective cohort study of 140 patients with stable CAD.
- Measurement of serum SAA/LDL complex using sandwich ELISA, alongside CRP and SAA levels.
- Defined endpoints included cardiac death, myocardial infarction, cerebral infarction, and coronary revascularization.
Main Results:
- 21 endpoint events occurred during the study period.
- Independent predictors of adverse events included age, diabetes mellitus, triglyceride levels, and SAA/LDL complex concentration.
- SAA/LDL complex (per 10 microg/ml) showed an odds ratio of 2.32 (CI: 1.05-4.70) for event occurrence.
- Reconstitution experiments indicated SAA/LDL complex formation via oxidative interaction between SAA and lipoproteins.
Conclusions:
- The SAA/LDL complex directly reflects intravascular inflammation.
- SAA/LDL complex serves as a novel, sensitive marker for predicting prognosis in stable CAD patients.
- This marker demonstrates superior predictive capability compared to CRP or SAA in this patient population.
Background:
Although some reports have indicated that acute phase proteins such as C-reactive protein (CRP) and serum amyloid A (SAA) can predict the prognosis in patients with acute coronary syndrome, the value of these markers in patients with stable coronary artery disease (CAD) still remains obscure. Therefore, our aim was to determine the prognostic value of inflammatory markers in patients with stable coronary artery disease.
Methods And Results:
We conducted a prospective cohort study in 140 consecutive patients with stable coronary artery disease who had at least one coronary stenosis more than 50% in diameter seen on diagnostic coronary angiography (CAG). We determined serum levels of the SAA/LDL complex as a new marker in addition to CRP and SAA. Serum levels of the SAA/LDL complex were measured by a sandwich enzyme-linked immunosorbent assay (ELISA). End-points were defined as cardiac death, myocardial infarction, cerebral infarction, and coronary revascularization. End-point events occurred in 21 patients (2 death from myocardial infarction, 2 cerebral infarction, and 17 revascularization). Age (year) (OR = 1.14, CI: 1.05-1.25), diabetes mellitus (OR = 3.50, CI: 1.08-11.40), triglyceride (10mg/dl) (OR = 1.12, CI: 1.01-1.23) and SAA/LDL complex (10 microg/ml) (OR = 2.32, CI: 1.05-4.70) were independently related to the events. A reconstitution experiment suggested that the SAA/LDL complex is derived by oxidative interaction between SAA and lipoproteins.
Conclusions:
The SAA/LDL complex reflects intravascular inflammation directly and can be a new marker more sensitive than CRP or SAA for prediction of prognosis in patients with stable coronary artery disease.
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease I: Introduction
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies